The TACS•XL® Kits use an biotinylated antibody to detect the incorporation of bromodeoxyuridine (BrdU) at the 3’ OH ends of the DNA fragments that are formed during apoptosis.  The combination of antibody specificity with the signal enhancing properties of biotin streptavidin results in precise cellular labeling and the highest signal-to-noise ratio observed in competitive testing.

Three general kit formats are available: TACS•XL® DAB, TACS•XL® Blue Label, and TACS•XL® Basic as well as a  DermaTACS™ tailored for detection of apoptosis in skin or epithelium sample.

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories